// App-Quantinova.ai

538 : Exploiting the properties of VNAR domains for the development of novel efficacious protein drug conjugates targeting the oncofetal protein ROR1

Researchers

Presenter

  • Graham Cotton

Principal Investigators

  • Jennifer Thom

  • Paul Trumper

  • Andrei Kamenski

  • Stacey Bell

  • Mark Wappett

  • Caroline Barelle

  • Marina Kovaleva

  • Alicia Campion

  • Elisa Persiani

  • Andrew Porter

  • Estelle McLean

  • Aidan McCann

  • Chiara Saladino

  • Aaron Cranston

  • Tim Harrison

Medical Centers

  • Almac Discovery, Edinburgh, United Kingdom

  • Elasmogen Ltd, Aberdeen, United Kingdom

  • Almac Discovery, Belfast, United Kingdom.

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Non Small Cell Lung cancer

  • Small cell lung cancer

  • Breast cancer

  • Solid malignancies

  • Lung Cancer

Biomarkers

  • Hepatocyte growth factor receptor

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved